Fecal High-Mobility Group Box 1 as a Marker of Early Stage of Necrotizing Enterocolitis in Preterm Neonates

Introduction: An early diagnosis of necrotizing enterocolitis (NEC), a major gastrointestinal emergency in preterm newborns, is crucial to improve diagnostic approach and prognosis. We evaluated whether fecal high-mobility group box protein 1 (HMGB1) may early identify preterms at risk of developing...

Full description

Bibliographic Details
Main Authors: Roberta Vitali, Gianluca Terrin, Francesca Palone, Ilaria Laudadio, Salvatore Cucchiara, Giovanni Boscarino, Maria Di Chiara, Laura Stronati
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-06-01
Series:Frontiers in Pediatrics
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fped.2021.672131/full
_version_ 1819063410105516032
author Roberta Vitali
Gianluca Terrin
Francesca Palone
Ilaria Laudadio
Salvatore Cucchiara
Giovanni Boscarino
Maria Di Chiara
Laura Stronati
author_facet Roberta Vitali
Gianluca Terrin
Francesca Palone
Ilaria Laudadio
Salvatore Cucchiara
Giovanni Boscarino
Maria Di Chiara
Laura Stronati
author_sort Roberta Vitali
collection DOAJ
description Introduction: An early diagnosis of necrotizing enterocolitis (NEC), a major gastrointestinal emergency in preterm newborns, is crucial to improve diagnostic approach and prognosis. We evaluated whether fecal high-mobility group box protein 1 (HMGB1) may early identify preterms at risk of developing NEC.Materials and Methods: A case-control study including neonates admitted at the Neonatal Intensive Care Unit (NICU) of the Sapienza University Hospital “Umberto I” in Rome, from July 2015 to December 2016. Stool samples obtained from cases (preterm newborns with NEC) and controls (newborns without NEC) were collected at the enrolment (T0) and within 7–14 days after the first sample collection (T1). HMGB1, extracted and measured with western blot, was reported as densitometry units (DUS).Results: HMGB1 levels in 30 cases (n = 28—Bell stage 1, n = 2 Bell stage 2) were higher [T0: 21,462 DUS (95% CI, 16,370–26,553 DUS)—T1: 17,533 DUS (95% CI, 13,052–22,014 DUS)] than in 30 preterm controls [T0: 9,446 DUS (95% CI, 6,147–12,746 DUS)—T1: 9,261 DUS (95% CI, 5,126–13,396 DUS), p < 0.001). Preterm newborns showed significant higher levels of HMGB1 (15,690 DUS (95% CI, 11,929–19,451 DUS)] in comparison with 30 full-term neonates with birth weight >2,500 g [6,599 DUS (95% CI, 3,141–10,058 DUS), p = 0.003]. Multivariate analysis showed that the risk of NEC was significantly (p = 0.012) related to the HMGB1 fecal levels at T0.Conclusions: We suggest fecal HMGB1 as a reliable marker of early NEC in preterm neonates. This study supports further investigation on the role of fecal HMGB1 assessment in managing preterm newborns at risk of NEC. Further studies are advocated to evaluate diagnostic accuracy of this marker in more severe forms of the disease.
first_indexed 2024-12-21T15:14:14Z
format Article
id doaj.art-4a1caf087e4f4d41858f3712ccd47ad9
institution Directory Open Access Journal
issn 2296-2360
language English
last_indexed 2024-12-21T15:14:14Z
publishDate 2021-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pediatrics
spelling doaj.art-4a1caf087e4f4d41858f3712ccd47ad92022-12-21T18:59:13ZengFrontiers Media S.A.Frontiers in Pediatrics2296-23602021-06-01910.3389/fped.2021.672131672131Fecal High-Mobility Group Box 1 as a Marker of Early Stage of Necrotizing Enterocolitis in Preterm NeonatesRoberta Vitali0Gianluca Terrin1Francesca Palone2Ilaria Laudadio3Salvatore Cucchiara4Giovanni Boscarino5Maria Di Chiara6Laura Stronati7Division of Health Protection Technologies, Territorial and Production Systems Sustainability Department, Agenzia nazionale per le nuove tecnologie, l'energia e lo sviluppo economico sostenibile (ENEA), Rome, ItalyDepartment of Maternal and Child Health, University of Roma La Sapienza, Rome, ItalyDivision of Health Protection Technologies, Territorial and Production Systems Sustainability Department, Agenzia nazionale per le nuove tecnologie, l'energia e lo sviluppo economico sostenibile (ENEA), Rome, ItalyDepartment of Molecular Medicine, Sapienza University of Rome, Rome, ItalyDepartment of Maternal and Child Health, University of Roma La Sapienza, Rome, ItalyDepartment of Maternal and Child Health, University of Roma La Sapienza, Rome, ItalyDepartment of Maternal and Child Health, University of Roma La Sapienza, Rome, ItalyDepartment of Molecular Medicine, Sapienza University of Rome, Rome, ItalyIntroduction: An early diagnosis of necrotizing enterocolitis (NEC), a major gastrointestinal emergency in preterm newborns, is crucial to improve diagnostic approach and prognosis. We evaluated whether fecal high-mobility group box protein 1 (HMGB1) may early identify preterms at risk of developing NEC.Materials and Methods: A case-control study including neonates admitted at the Neonatal Intensive Care Unit (NICU) of the Sapienza University Hospital “Umberto I” in Rome, from July 2015 to December 2016. Stool samples obtained from cases (preterm newborns with NEC) and controls (newborns without NEC) were collected at the enrolment (T0) and within 7–14 days after the first sample collection (T1). HMGB1, extracted and measured with western blot, was reported as densitometry units (DUS).Results: HMGB1 levels in 30 cases (n = 28—Bell stage 1, n = 2 Bell stage 2) were higher [T0: 21,462 DUS (95% CI, 16,370–26,553 DUS)—T1: 17,533 DUS (95% CI, 13,052–22,014 DUS)] than in 30 preterm controls [T0: 9,446 DUS (95% CI, 6,147–12,746 DUS)—T1: 9,261 DUS (95% CI, 5,126–13,396 DUS), p < 0.001). Preterm newborns showed significant higher levels of HMGB1 (15,690 DUS (95% CI, 11,929–19,451 DUS)] in comparison with 30 full-term neonates with birth weight >2,500 g [6,599 DUS (95% CI, 3,141–10,058 DUS), p = 0.003]. Multivariate analysis showed that the risk of NEC was significantly (p = 0.012) related to the HMGB1 fecal levels at T0.Conclusions: We suggest fecal HMGB1 as a reliable marker of early NEC in preterm neonates. This study supports further investigation on the role of fecal HMGB1 assessment in managing preterm newborns at risk of NEC. Further studies are advocated to evaluate diagnostic accuracy of this marker in more severe forms of the disease.https://www.frontiersin.org/articles/10.3389/fped.2021.672131/fullfeeding intoleranceHMGB1necrotizing enterocolitisnewbornspreterm
spellingShingle Roberta Vitali
Gianluca Terrin
Francesca Palone
Ilaria Laudadio
Salvatore Cucchiara
Giovanni Boscarino
Maria Di Chiara
Laura Stronati
Fecal High-Mobility Group Box 1 as a Marker of Early Stage of Necrotizing Enterocolitis in Preterm Neonates
Frontiers in Pediatrics
feeding intolerance
HMGB1
necrotizing enterocolitis
newborns
preterm
title Fecal High-Mobility Group Box 1 as a Marker of Early Stage of Necrotizing Enterocolitis in Preterm Neonates
title_full Fecal High-Mobility Group Box 1 as a Marker of Early Stage of Necrotizing Enterocolitis in Preterm Neonates
title_fullStr Fecal High-Mobility Group Box 1 as a Marker of Early Stage of Necrotizing Enterocolitis in Preterm Neonates
title_full_unstemmed Fecal High-Mobility Group Box 1 as a Marker of Early Stage of Necrotizing Enterocolitis in Preterm Neonates
title_short Fecal High-Mobility Group Box 1 as a Marker of Early Stage of Necrotizing Enterocolitis in Preterm Neonates
title_sort fecal high mobility group box 1 as a marker of early stage of necrotizing enterocolitis in preterm neonates
topic feeding intolerance
HMGB1
necrotizing enterocolitis
newborns
preterm
url https://www.frontiersin.org/articles/10.3389/fped.2021.672131/full
work_keys_str_mv AT robertavitali fecalhighmobilitygroupbox1asamarkerofearlystageofnecrotizingenterocolitisinpretermneonates
AT gianlucaterrin fecalhighmobilitygroupbox1asamarkerofearlystageofnecrotizingenterocolitisinpretermneonates
AT francescapalone fecalhighmobilitygroupbox1asamarkerofearlystageofnecrotizingenterocolitisinpretermneonates
AT ilarialaudadio fecalhighmobilitygroupbox1asamarkerofearlystageofnecrotizingenterocolitisinpretermneonates
AT salvatorecucchiara fecalhighmobilitygroupbox1asamarkerofearlystageofnecrotizingenterocolitisinpretermneonates
AT giovanniboscarino fecalhighmobilitygroupbox1asamarkerofearlystageofnecrotizingenterocolitisinpretermneonates
AT mariadichiara fecalhighmobilitygroupbox1asamarkerofearlystageofnecrotizingenterocolitisinpretermneonates
AT laurastronati fecalhighmobilitygroupbox1asamarkerofearlystageofnecrotizingenterocolitisinpretermneonates